Fast, Non-Competitive and Reversible Inhibition of NMDA-Activated Currents by 2-BFI Confers Neuroprotection

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Han, Zhao ^a   Yang, Jin Long ^a   Jiang, Susan X ^b   Hou, Sheng Tao ^b   Zheng, Rong Yuan ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM; IMIDAZOLINE DERIVATIVE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EMBRYO; EXCITOTOXICITY; IN VITRO STUDY; MALE; NERVE CELL CULTURE; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; RAT;

ANIMALS; BENZOFURANS; CALCIUM; CALCIUM SIGNALING; CEREBRAL CORTEX; IMIDAZOLES; KINETICS; MALE; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; PROTEIN BINDING; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

RATTUS; RODENTIA;

EID: 84878651633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064894     Document Type: Article

References (37)

1. Hou ST, MacManus JP, (2002) Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol 221: 93-148.
2. Hewitt KE, Lesiuk HJ, Tauskela JS, Morley P, Durkin JP, (1998) Selective coupling of mu-calpain activation with the NMDA receptor is independent of translocation and autolysis in primary cortical neurons. J Neurosci Res 54: 223-232.
3. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, et al. (2001) Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170: 27-35.
4. Szydlowska K, Tymianski M, (2010) Calcium, ischemia and excitotoxicity. Cell Calcium 47: 122-129.
5. Moskowitz MA, Lo EH, Iadecola C, (2010) The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198.
6. Lipton SA, (2007) Pathologically activated therapeutics for neuroprotection. Nat Rev Neurosci 8: 803-808.
7. Lipton SA, (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5: 160-170.
8. Stieg PE, Sathi S, Warach S, Le DA, Lipton SA, (1999) Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. Eur J Pharmacol 375: 115-120.
9. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, et al. (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12: 4427-4436.
10. Chen HS, Lipton SA, (2006) The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97: 1611-1626.
11. Lipton SA, Chen HS, (2005) Paradigm shift in NMDA receptor drug development. Expert Opin Ther Targets 9: 427-429.
12. Gilling KE, Jatzke C, Hechenberger M, Parsons CG, (2009) Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors. Neuropharmacology 56: 866-875.
13. Gilling KE, Jatzke C, Parsons CG, (2007) Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine. Neuropharmacology 53: 415-420.
14. Parsons CG, Gilling KE, Jatzke C, (2008) Memantine does not show intracellular block of the NMDA receptor channel. Eur J Pharmacol 587: 99-103.
15. Han Z, Xiao MJ, Shao B, Zheng RY, Yang GY, et al. (2009) Attenuation of ischemia-induced rat brain injury by 2-(-2-benzofuranyl)-2-imidazoline, a high selectivity ligand for imidazoline I(2) receptors. Neurol Res 31: 390-395.
16. Han Z, Zhang HX, Tian JS, Zheng RY, Hou ST, (2010) 2-(-2-benzofuranyl)-2-imidazoline induces Bcl-2 expression and provides neuroprotection against transient cerebral ischemia in rats. Brain Res 1361: 86-92.
17. Han Z, Cheng ZH, Liu S, Yang JL, Xiao MJ, et al. (2012) Neurovascular protection conferred by 2-BFI treatment during rat cerebral ischemia. Biochem Biophys Res Commun 424: 544-548.
18. Alemany R, Olmos G, Garcia-Sevilla JA, (1997) Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn Schmiedebergs Arch Pharmacol 356: 39-47.
19. Olmos G, Ribera J, Garcia-Sevilla JA, (1996) Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain. Eur J Pharmacol 310: 273-276.
20. Milhaud D, Fagni L, Bockaert J, Lafon-Cazal M, (2000) Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures. Neuropharmacology 39: 2244-2254.
21. Milhaud D, Fagni L, Bockaert J, Lafon-Cazal M, (2002) Inhibition of voltage-gated Ca2+ channels by antazoline. Neuroreport 13: 1711-1714.
22. Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA, (2008) Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest Ophthalmol Vis Sci 49: 4515-4522.
23. Jiang SX, Zheng RY, Zeng JQ, Li XL, Han Z, et al. (2010) Reversible inhibition of intracellular calcium influx through NMDA receptors by imidazoline I(2) receptor antagonists. Eur J Pharmacol 629: 12-19.
24. Hou ST, Jiang SX, Desbois A, Huang D, Kelly J, et al. (2006) Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. J Neurosci 26: 2241-2249.
25. Jiang SX, Lertvorachon J, Hou ST, Konishi Y, Webster J, et al. (2005) Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia. J Biol Chem 280: 33811-33818.
26. Smith RA, Walker T, Xie X, Hou ST, (2003) Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Brain Res Mol Brain Res 116: 70-79.
27. Lipton SA, Chen HS, (2004) Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine. Cell Death Differ 11: 18-20.
28. Wang XS, Chen YY, Shang XF, Zhu ZG, Chen GQ, et al. (2009) Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis. Brain Res 1253: 198-209.
29. Wang P, Wang ZW, Lin FH, Han Z, Hou ST, et al. (2011) 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity. Biochem Biophys Res Commun 406: 152-157.
30. Head GA, Mayorov DN, (2006) Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 4: 17-32.
31. Simon R, Xiong Z, (2006) Acidotoxicity in brain ischaemia. Biochem Soc Trans 34: 1356-1361.
32. Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, et al. (2004) Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118: 687-698.
33. Du W, Huang J, Yao H, Zhou K, Duan B, et al. (2010) Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats. J Clin Invest 120: 3480-3492.
34. Hou ST, Jiang SX, Smith RA, (2008) Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int Rev Cell Mol Biol 267: 125-181.
35. Lo EH, Dalkara T, Moskowitz MA, (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415.
36. Choi DW, (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 11: 465-469.
37. Culmsee C, Junker V, Kremers W, Thal S, Plesnila N, et al. (2004) Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke 35: 1197-1202.